Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000146

Director sold 20,000 shares at an average $30.27 ($605,463)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessier-Lavigne Marc Director 2022-11-01 Sale −8,748 $30.20 $264,190 1,901,608 D
Tessier-Lavigne Marc Director 2022-11-02 Sale −11,252 $30.33 $341,273 1,890,356 D
Open-market sales · 20,000 sh · avg $30.27 · $605,463
Loading xslF345X03/wf-form4_166751143725460.xml…